Suppliers / Shanghai Huilun Pharmaceutical

Shanghai Huilun Pharmaceutical

China 13 employees Updated 9 July 2026

Shanghai Huilun Pharmaceutical is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Cabozantinib US FDA 1
Ticagrelor US FDA 1

Also appears on these molecule pages

Cabozantinib API Ticagrelor API

Questions about Shanghai Huilun Pharmaceutical

Does Shanghai Huilun Pharmaceutical hold a US DMF or a CEP?
Shanghai Huilun Pharmaceutical holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Shanghai Huilun Pharmaceutical make?
2 molecules are on record against Shanghai Huilun Pharmaceutical, including Cabozantinib and Ticagrelor. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shanghai Huilun Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

MSN Laboratories shares 1 molecule Dr Reddy's Laboratories shares 1 molecule Changzhou Pharmaceutical Factory shares 1 molecule Natco Pharma shares 1 molecule Biocon shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability